Lasa Supergenerics announced that the 9th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net Loss of Lasa Supergenerics reported to Rs 2.73 crore in the quarter ended June 2024 as against net loss of Rs 4.95 crore during the previous quarter ended June 2023. Sales rose 0.92% to Rs 30.84 crore in the quarter ended June 2024 as against Rs 30.56 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales30.8430.56 1 OPM %5.8413.25 - PBDT0.933.68 -75 PBT-1.861.03 PL NP-2.73-4.95 45 Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News

Net Loss of Lasa Supergenerics reported to Rs 15.30 crore in the quarter ended March 2024 as against net loss of Rs 15.00 crore during the previous quarter ended March 2023. Sales declined 35.39% to Rs 22.82 crore in the quarter ended March 2024 as against Rs 35.32 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 21.73 crore in the year ended March 2024 as against net loss of Rs 38.62 crore during the previous year ended March 2023. Sales declined 19.47% to Rs 104.34 crore in the year ended March 2024 as against Rs 129.57 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales22.8235.32 -35 104.34129.57 -19 OPM %-17.4812.29 -2.07-5.08 - PBDT-4.544.86 PL 0.33-8.94 LP PBT-7.200.69 PL -10.34-22.36 54 NP-15.30-15.00 -2 -21.73-38.62 44 Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News